PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
S. kali pollen is a major allergen source causing hay-fever, asthma, and allergic skin symptoms [PMID:38911871].
A double-blind, placebo-controlled trial evaluated a depigmented and glutaraldehyde-polymerized therapeutic vaccine to assess clinical efficacy in patients with rhinoconjunctivitis [PMID:16630938].
Direct contact with Russian thistle can cause dermatitis; in non-sensitized persons, this is due to mechanical irritation of floral bracts, while sensitized individuals experience an urticarial reaction [PMID:646398].
Evidence summary
PubMed sources
- 1.PMID: 646398 (1978) — Tumbleweed dermatitis. · Archives of dermatology
- 2.PMID: 38911871 (2024) — The cytoskeletal protein profilin is an important allergen in saltwort (Salsola kali). · Frontiers in immunology
- 3.PMID: 36919921 (2023) — Pharmacognostical evaluation and physiochemical analysis of Salsola Kali as medicinal plant. · Microscopy research and technique
- 4.PMID: 16630938 (2006) — Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. · The Journal of allergy and clinical immunology
- 5.PMID: 14616126 (2003) — Immunochemical characterization of Russian thistle (Salsola kali) pollen extracts. Purification of the allergen Sal k 1.